Invention Application
- Patent Title: A METHOD FOR QUANTIFYING BEVACIZUMAB
- Patent Title (中): 一种量化BEVACIZUMAB的方法
-
Application No.: PCT/EP2016/072421Application Date: 2016-09-21
-
Publication No.: WO2017050825A1Publication Date: 2017-03-30
- Inventor: LEGERON, Rachel , XUEREB, Fabien , BREILH, Dominique , GADEAU, Alain Pierre , BOIRON, Jean-Michel , SCHMITTER, Jean-Marie , DUPUY, Jean-William , CHAIGNEPAIN, Stéphane
- Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , UNIVERSITÉ DE BORDEAUX , CHU DE BORDEAUX , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Applicant Address: 101, Rue de Tolbiac 75013 Paris FR
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITÉ DE BORDEAUX,CHU DE BORDEAUX,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITÉ DE BORDEAUX,CHU DE BORDEAUX,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee Address: 101, Rue de Tolbiac 75013 Paris FR
- Agency: VEINANTE, Aude et al.
- Priority: EP15306468.8 20150921
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/34
Abstract:
The present invention relates to the use of an Internal Standard compound in a method for quantifying Bevacizumab in a sample by mass spectrometry, wherein the said Internal Standard compound is described in the specification.
Information query
